beta-D-Glcp-(1->2)-[beta-D-Glcp-(1->3)]-alpha-D-Glcp

Term ID

CHEBI:146924

Synonyms

(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5R,6R)-2,5-Dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-4-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
beta-D-gluco-hexopyranosyl-(1->2)-[beta-D-gluco-hexopyranosyl-(1->3)]-alpha-D-gluco-hexopyranose
beta-D-glucopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->3)]-alpha-D-glucopyranose
Glc(b1-2)[Glc(b1-3)]a-Glc

Definition

A glucotriose consisting of α-D-glucopyranose in which the hydroxy groups at 2 and 3 have each been converted into the corresponding β-D-glucopyranosyl derivatives.

References

glygen:G06100IY
glytoucan:G06100IY

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from beta-D-Glcp-(1->2)-[beta-D-Glcp-(1->3)]-alpha-D-Glcp

Phenotype where environments contain beta-D-Glcp-(1->2)-[beta-D-Glcp-(1->3)]-alpha-D-Glcp

Phenotype modified by environments containing beta-D-Glcp-(1->2)-[beta-D-Glcp-(1->3)]-alpha-D-Glcp

Phenotype affecting beta-D-Glcp-(1->2)-[beta-D-Glcp-(1->3)]-alpha-D-Glcp

Human Disease Model